RGT Argent BioPharma Limited
—Mkt Cap: —P/E: —1d ago
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and the United King…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value8.70M USD
Revenue (TTM)111.39K USD
Gross Profit308.45K USD
Net Income (TTM)-12.33M USD
Revenue/Share0.0020 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU0000326647
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.71
EV/Revenue78.14
P/S19.74
P/B-0.32
EPS (TTM)-0.09
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin76.50%
Oper. Margin43133.83%
EBITDA Margin0.00%
Profit Margin-3058.43%
ROE206.77%
ROA-723.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.78M USD
CapEx (TTM)1.54K USD
FCF Margin-1332.46%
FCF Yield—
Net Debt6.53M USD
Net Debt/EBITDA-1.28
Balance Sheet
Debt/Equity-0.96
Current Ratio0.05
Quick Ratio0.04
Book Value/Sh-0.09 AUD
Cash/Share0.0010 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateOct 30, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.117.86M
Float40.11M
Insiders62.59%
Institutions0.00%
Technical
SMA 500.0333 AUD
SMA 2000.0428 AUD
Beta0.52
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)81.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—